Get started
RocketTickers

Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinep

Long
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)  
RocketTickers  
NASDAQ:AMPH   Amphastar Pharmaceuticals, Inc.
Beyond Technical Analysis
4
0
beyondta
AMPH: Amphastar Pharmaceuticals, Inc.
2020-04-27 06:00:10
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.